Botticelli A - Search Results

1

Anti-PD-1 and Anti-PD-L1 in Head and Neck Cancer: A Network Meta-Analysis.

Botticelli A, Cirillo A, Strigari L, Valentini F, Cerbelli B, Scagnoli S, Cerbelli E, Zizzari IG, Rocca CD, D'Amati G, Polimeni A, Nuti M, Merlano MC, Mezi S, Marchetti P. Botticelli A, et al. Front Immunol. 2021 Aug 9;12:705096. doi: 10.3389/fimmu.2021.705096. eCollection 2021. Front Immunol. 2021. PMID: 34434192 Free PMC article.

2

Electrochemotherapy treatment of cutaneous metastases from breast cancer.

Mercantini P, Lorenzon L, Tarantino G, Balducci G, Ferri M, Mazzuca F, Botticelli A, Marchetti P. Mercantini P, et al. Among authors: botticelli a. Am Surg. 2015 May;81(5):E222-5. Am Surg. 2015. PMID: 25975317 No abstract available.

3

Positive impact of elastography in breast cancer diagnosis: an institutional experience.

Botticelli A, Mazzotti E, Di Stefano D, Petrocelli V, Mazzuca F, La Torre M, Ciabatta FR, Giovagnoli RM, Marchetti P, Bonifacino A. Botticelli A, et al. J Ultrasound. 2015 Aug 12;18(4):321-7. doi: 10.1007/s40477-015-0177-y. eCollection 2015 Dec. J Ultrasound. 2015. PMID: 26550070 Free PMC article.

4

Pre-treatment evaluation of 5-fluorouracil degradation rate: association of poor and ultra-rapid metabolism with severe toxicity in a colorectal cancer patients cohort.

Mazzuca F, Borro M, Botticelli A, Mazzotti E, Marchetti L, Gentile G, La Torre M, Lionetto L, Simmaco M, Marchetti P. Mazzuca F, et al. Among authors: botticelli a. Oncotarget. 2016 Apr 12;7(15):20612-20. doi: 10.18632/oncotarget.7991. Oncotarget. 2016. PMID: 26967565 Free PMC article.

5

CYP19A1 Genetic Polymorphisms rs4646 and Osteoporosis in Patients Treated with Aromatase Inhibitor-Based Adjuvant Therapy.

Mazzuca F, Botticelli A, Mazzotti E, La Torre M, Borro M, Marchetti L, Maddalena C, Gentile G, Simmaco M, Marchetti P. Mazzuca F, et al. Among authors: botticelli a. Eurasian J Med. 2016 Feb;48(1):10-4. doi: 10.5152/eurasianjmed.2015.008. Epub 2015 Jul 7. Eurasian J Med. 2016. PMID: 27026757 Free PMC article.

6

Degradation Rate of 5-Fluorouracil in Metastatic Colorectal Cancer: A New Predictive Outcome Biomarker?

Botticelli A, Borro M, Onesti CE, Strigari L, Gentile G, Cerbelli B, Romiti A, Occhipinti M, Sebastiani C, Lionetto L, Marchetti L, Simmaco M, Marchetti P, Mazzuca F. Botticelli A, et al. PLoS One. 2016 Sep 22;11(9):e0163105. doi: 10.1371/journal.pone.0163105. eCollection 2016. PLoS One. 2016. PMID: 27656891 Free PMC article.

7

Pre-treatment assay of 5-fluorouracil degradation rate (5-FUDR) to improve prediction of 5-fluorouracil toxicity in gastro-esophageal cancer.

Borro M, Botticelli A, Mazzuca F, Onesti EC, Gentile G, Romiti A, Cerbelli B, Mazzotti E, Marchetti L, Lionetto L, Simmaco M, Marchetti P. Borro M, et al. Among authors: botticelli a. Oncotarget. 2017 Feb 21;8(8):14050-14057. doi: 10.18632/oncotarget.12571. Oncotarget. 2017. PMID: 27738344 Free PMC article.

8

Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment.

Botticelli A, Zizzari I, Mazzuca F, Ascierto PA, Putignani L, Marchetti L, Napoletano C, Nuti M, Marchetti P. Botticelli A, et al. Oncotarget. 2017 Jan 31;8(5):8890-8899. doi: 10.18632/oncotarget.12985. Oncotarget. 2017. PMID: 27806346 Free PMC article. Review.

9

5-Fluorouracil degradation rate could predict toxicity in stages II-III colorectal cancer patients undergoing adjuvant FOLFOX.

Onesti CE, Botticelli A, La Torre M, Borro M, Gentile G, Romiti A, Lionetto L, Petremolo A, Occhipinti M, Roberto M, Falcone R, Simmaco M, Marchetti P, Mazzuca F. Onesti CE, et al. Among authors: botticelli a. Anticancer Drugs. 2017 Mar;28(3):322-326. doi: 10.1097/CAD.0000000000000453. Anticancer Drugs. 2017. PMID: 27845948

10

A nomogram to predict 5-fluorouracil toxicity: when pharmacogenomics meets the patient.

Botticelli A, Onesti CE, Strigari L, Occhipinti M, Di Pietro FR, Cerbelli B, Petremolo A, Anselmi E, Macrini S, Roberto M, Falcone R, Lionetto L, Borro M, Milano A, Gentile G, Simmaco M, Marchetti P, Mazzuca F. Botticelli A, et al. Anticancer Drugs. 2017 Jun;28(5):551-556. doi: 10.1097/CAD.0000000000000492. Anticancer Drugs. 2017. PMID: 28296649

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

282 results

Search Page